Search for information about a product,
therapeutic area or event

Search

Media, investors, advocacy organizations and others, please contact us here.

Welcome to Travere Therapeutics
Global Medical Affairs

At Travere Therapeutics Global Medical Affairs,
we are dedicated to sharing scientific knowledge, collaborating with experts,
and innovation for improved rare disease outcomes.

Webinar

A New Dawn for IgA Nephropathy – Redefining What is Possible with Sparsentan

Travere Therapeutics and the International Society of Nephrology (ISN) bring you a webinar on the place of sparsentan in the evolving therapeutic landscape of IgA nephropathy

The First Ever FSGS Awareness Day is June 10th

Talk to your MSL to learn more about podocyte damage in focal segmental glomerulosclerosis (FSGS) and the significant unmet treatment needs.

Find your MSL in the menu above.

Also join us on X for ongoing insights.
National Kidney Foundation (NKF) Spring Clinical Meetings 2025
Travere at NKF 2025

National Kidney Foundation (NKF) Spring Clinical Meetings 2025

The Spring Clinical Meetings is the premiere educational event presented by the National Kidney Foundation. The event is designed for interprofessional kidney health teams.

Our Latest Publications

Publications IgAN Nephrology

Efficacy and Safety of Sparsentan Versus Irbesartan in Patients with IgA Nephropathy (PROTECT): 2-Year Results From a Randomised Active-Controlled Phase 3 Trial

The Lancet
2023

Learn more

Latest Podcast Episode

Podcast
Rare Kidney Disease

Episode 6

Introduction to FSGS:
Ft. Dr. Howard Trachtman

View all publications

Upcoming Events

Events

62nd European Renal Association (ERA) Congress 2025

June 4 – 7, 2025

Vienna, Austria

Learn more Schedule a Meeting
Events

15th International Podocyte Conference and 2025 ISGD Meeting

June 10 – 13, 2025

Hamburg, Germany

Learn more Schedule a Meeting
Events

International IgAN Symposium 2025

September 17 – 20, 2025

Prague, Czech Republic

Learn more Schedule a Meeting
View all events

Recent posters & presentations

e-Poster

Patients in DUPLEX Achieved Partial or Complete Remission of Proteinuria Earlier and More Often With Sparsentan vs Irbesartan: Implications for Slowing Progression to Kidney Failure in Focal Segmental Glomerulosclerosis (FSGS)
e-Poster

Sparsentan as First-Line Treatment of Incident Patients With IgA Nephropathy (IgAN): Interim Analysis of the SPARTAN Trial
e-Poster

Implications of Proteinuria Remission on Estimated Glomerular Filtration Rate Trajectory in Patients With IgA Nephropathy in PROTECT
View all event materials

Find an MSL

Find and connect your local Medical Science Liaison (MSL) for support related to Travere products.

Find your MSL

Search for Medical Information

Have questions?
Find scientific, evidence-based, and balanced information about Travere products.

Start a search